DK1326838T3 - Nye krystalformer af en inhibitor af faktor xa - Google Patents
Nye krystalformer af en inhibitor af faktor xaInfo
- Publication number
- DK1326838T3 DK1326838T3 DK01979459T DK01979459T DK1326838T3 DK 1326838 T3 DK1326838 T3 DK 1326838T3 DK 01979459 T DK01979459 T DK 01979459T DK 01979459 T DK01979459 T DK 01979459T DK 1326838 T3 DK1326838 T3 DK 1326838T3
- Authority
- DK
- Denmark
- Prior art keywords
- inhibitor
- factor
- crystal forms
- novel crystal
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Liquid Crystal Substances (AREA)
- Compounds Of Unknown Constitution (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23831600P | 2000-10-05 | 2000-10-05 | |
| GBGB0108903.6A GB0108903D0 (en) | 2000-10-05 | 2001-04-10 | Novel crystalline forms of a factor Xa inhibitor |
| PCT/US2001/031087 WO2002028836A1 (en) | 2000-10-05 | 2001-10-04 | Novel crystalline forms of a factor xa inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1326838T3 true DK1326838T3 (da) | 2008-09-22 |
Family
ID=22897372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01979459T DK1326838T3 (da) | 2000-10-05 | 2001-10-04 | Nye krystalformer af en inhibitor af faktor xa |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7034160B2 (da) |
| EP (1) | EP1326838B1 (da) |
| JP (1) | JP4177663B2 (da) |
| AT (1) | ATE396177T1 (da) |
| AU (2) | AU1142502A (da) |
| CA (1) | CA2424565C (da) |
| CY (1) | CY1108224T1 (da) |
| DK (1) | DK1326838T3 (da) |
| ES (1) | ES2304396T3 (da) |
| GB (1) | GB0108903D0 (da) |
| IL (1) | IL155189A (da) |
| MX (1) | MXPA03002067A (da) |
| PT (1) | PT1326838E (da) |
| WO (1) | WO2002028836A1 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6964784B2 (en) * | 2002-03-07 | 2005-11-15 | Optigenex, Inc. | Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals |
| RU2597423C2 (ru) * | 2011-03-29 | 2016-09-10 | Санофи | Бензойнокислая соль отамиксабана |
| KR101844623B1 (ko) * | 2011-03-29 | 2018-04-02 | 사노피 | 안정성이 향상된 오타믹사반 제제 |
| TWI551289B (zh) * | 2011-03-29 | 2016-10-01 | 賽諾菲公司 | 具有改良之安定性之奧米沙班調配物 |
| NZ731932A (en) | 2012-06-04 | 2018-09-28 | Pharmacyclics Llc | Crystalline forms of a bruton’s tyrosine kinase inhibitor |
| JP2017523206A (ja) | 2014-08-07 | 2017-08-17 | ファーマサイクリックス エルエルシー | ブルトン型チロシンキナーゼ阻害剤の新規製剤 |
| IL315294A (en) | 2015-03-03 | 2024-10-01 | Pharmacyclics Llc | Pharmaceutical formulations of bruton's tyrosine kinase inhibitor |
| MA41827A (fr) * | 2015-03-27 | 2018-01-30 | Pharmacyclics Llc | Formes solvatées d'un inhibiteur de la tyrosine kinase de bruton |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6080767A (en) * | 1996-01-02 | 2000-06-27 | Aventis Pharmaceuticals Products Inc. | Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| DE69628856T2 (de) * | 1996-01-02 | 2004-05-06 | Aventis Pharmaceuticals Inc. | Substituierte n-[(aminoiminomethyl oder aminomethyl)phenyl]propylamide |
-
2001
- 2001-04-10 GB GBGB0108903.6A patent/GB0108903D0/en not_active Ceased
- 2001-10-04 JP JP2002532422A patent/JP4177663B2/ja not_active Expired - Fee Related
- 2001-10-04 PT PT01979459T patent/PT1326838E/pt unknown
- 2001-10-04 AT AT01979459T patent/ATE396177T1/de active
- 2001-10-04 MX MXPA03002067A patent/MXPA03002067A/es active IP Right Grant
- 2001-10-04 CA CA2424565A patent/CA2424565C/en not_active Expired - Fee Related
- 2001-10-04 AU AU1142502A patent/AU1142502A/xx active Pending
- 2001-10-04 AU AU2002211425A patent/AU2002211425B2/en not_active Ceased
- 2001-10-04 EP EP01979459A patent/EP1326838B1/en not_active Expired - Lifetime
- 2001-10-04 DK DK01979459T patent/DK1326838T3/da active
- 2001-10-04 ES ES01979459T patent/ES2304396T3/es not_active Expired - Lifetime
- 2001-10-04 WO PCT/US2001/031087 patent/WO2002028836A1/en active Application Filing
-
2003
- 2003-04-01 IL IL155189A patent/IL155189A/en not_active IP Right Cessation
- 2003-04-01 US US10/404,678 patent/US7034160B2/en not_active Expired - Lifetime
-
2008
- 2008-07-29 CY CY20081100790T patent/CY1108224T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU1142502A (en) | 2002-04-15 |
| AU2002211425B2 (en) | 2006-03-02 |
| IL155189A (en) | 2011-11-30 |
| GB0108903D0 (en) | 2001-05-30 |
| PT1326838E (pt) | 2008-07-08 |
| EP1326838B1 (en) | 2008-05-21 |
| WO2002028836A9 (en) | 2003-11-20 |
| CY1108224T1 (el) | 2014-02-12 |
| US7034160B2 (en) | 2006-04-25 |
| EP1326838A1 (en) | 2003-07-16 |
| CA2424565A1 (en) | 2002-04-11 |
| WO2002028836A1 (en) | 2002-04-11 |
| CA2424565C (en) | 2011-04-26 |
| MXPA03002067A (es) | 2003-06-24 |
| JP2004521082A (ja) | 2004-07-15 |
| ATE396177T1 (de) | 2008-06-15 |
| ES2304396T3 (es) | 2008-10-16 |
| US20030225144A1 (en) | 2003-12-04 |
| JP4177663B2 (ja) | 2008-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0015836A (pt) | Cristal de 4-carboxiamino-2-etil-1,2,3,4-tetra-hidroquinolina como inibidor de cetp | |
| EA200500203A1 (ru) | Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат | |
| DE602004008098D1 (de) | Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren | |
| NO20062021L (no) | Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika | |
| BR0317715A (pt) | Composições e processos de uso de collajolie | |
| CO5611065A2 (es) | Difluorometiltiazolilcarboxanilidas | |
| ATE490253T1 (de) | Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen | |
| CY1112653T1 (el) | Κρυσταλλικες τροποποιησεις της πυρακλοστροβινης | |
| NO20051082L (no) | Antimikrobielle kinoloner, deres sammensetninger og anvendelser | |
| CY1108224T1 (el) | Καινοτομες κρυσταλλικες μορφες ενος αναστολεα του παραγοντα χα | |
| SE0403171D0 (sv) | New compounds | |
| SE0302139D0 (sv) | Novel compounds | |
| ATE427953T1 (de) | Fondaparinux- natrium zusammenstellung von hoher reinheit | |
| ATE440833T1 (de) | Antithrombotische diamide | |
| DE50113345D1 (de) | Arginin-mimetika als faktor xa-inhibitoren | |
| SE0103710D0 (sv) | Compounds | |
| RS94603A (en) | Novel compounds and compositions as cathepsin inhibitors | |
| ATE359283T1 (de) | Substituierte pyrazinonverbindungen zur behandlung von entzündungen | |
| DE50310579D1 (de) | Furancarboxamide | |
| WO2006047415A3 (en) | FACTOR Xa COMPOUNDS | |
| SE9903290D0 (sv) | Novel compounds | |
| RS20060206A (en) | Aminopyridine-derivatives as inducible no-synthase inhibitors | |
| ATE348800T1 (de) | 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren | |
| DE50311756D1 (de) | Mikrobizide oxathiincarboxamide | |
| SE0302755D0 (sv) | Novel compounds |